Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Biosimilarity of Gan & Lee Insulin Lispro vs Humalog
NCT04235439Phase 1Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Apr 2019
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin lispro in diabetes mellitus (DM) (3 arms), sponsored by Gan & Lee Pharmaceuticals. Primary endpoints: Area Under the Serum Insulin Concentration-Time Curve from 0 to 12 Hours, Maximum Serum Insulin Concentration and 2 more. Started Apr 2019; status: completed.
02
Drugs
insulin lispro
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT04235439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04235439.